Organogenesis Holdings 2026 Annual Meeting Results and Director Re-election

Organogenesis Holdings Inc. filed an 8-K reporting the results of its 2026 Annual Meeting of Stockholders held on June 15, 2026. The company announced that nine directors were re-elected to the board: Robert Ades, Michael J. Driscoll, Prathyusha Duraibabu, Jon Giacomin, Gary S. Gillheeney, Sr., Michele Korfin, Arthur S. Leibowitz, Glenn H. Nussdorf, and Gilberto Quintero. Additionally, Garrett Lustig was re-elected to the board by holders of Series A Convertible Preferred Stock through written consent. Stockholders approved three proposals: the election of directors, advisory approval of executive compensation (72.5 million for, 12.7 million against), and ratification of RSM US LLP as independent auditor for fiscal year 2026 (128.4 million for, 857,000 against). A total of 129.6 million shares were represented at the meeting, including 38.5 million shares issuable upon conversion of Series A Convertible Preferred Stock.